Studies using the APL‐derived NB4 cell model have shown that shikonin, compared to controls, significantly suppresses the phosphorylation of PI3K, Akt, and mTOR by modulating the PI3K/Akt/mTOR signaling pathway. This evidence concerns the gene AKT1 and acute promyelocytic leukemia.